Literature DB >> 27373531

Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.

Hajime Shishido1, Yasushi Kishimoto2, Nobuyuki Kawai3, Yasunori Toyota1, Masaki Ueno4, Takashi Kubota5, Yutaka Kirino5, Takashi Tamiya1.   

Abstract

Several pathological and epidemiological studies have demonstrated a possible relationship between traumatic brain injury (TBI) and Alzheimer's disease (AD). However, the exact contribution of TBI to AD onset and progression is unclear. Hence, we examined AD-related histopathological changes and cognitive impairment after TBI in triple transgenic (3×Tg)-AD model mice. Five- to seven-month-old 3×Tg-AD model mice were subjected to either TBI by the weight-drop method or a sham treatment. In the 3×Tg-AD mice subjected to TBI, the spatial learning was not significantly different 7 days after TBI compared to that of the sham-treated 3×Tg-AD mice. However, 28 days after TBI, the 3×Tg-AD mice exhibited significantly lower spatial learning than the sham-treated 3×Tg-AD mice. Correspondingly, while a few amyloid-β (Aβ) plaques were observed in both sham-treated and TBI-treated 3×Tg-AD mouse hippocampus 7 days after TBI, the Aβ deposition was significantly greater in 3×Tg-AD mice 28 days after TBI. Thus, we demonstrated that TBI induced a significant increase in hippocampal Aβ deposition 28 days after TBI compared to that of the control animals, which was associated with worse spatial learning ability in 3×Tg-AD mice. The present study suggests that TBI could be a risk factor for accelerated AD progression, particularly when genetic and hereditary predispositions are involved.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-β protein; Cognitive impairment; Traumatic brain injury; Triple-transgenic AD-model mouse

Mesh:

Substances:

Year:  2016        PMID: 27373531     DOI: 10.1016/j.neulet.2016.06.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Traumatic Brain Injury Alters the Metabolism and Facilitates Alzheimer's Disease in a Murine Model.

Authors:  Dandan Lou; Yao Du; Daochao Huang; Fang Cai; Yun Zhang; Tinyu Li; Weihui Zhou; Hongchang Gao; Weihong Song
Journal:  Mol Neurobiol       Date:  2017-08-03       Impact factor: 5.590

2.  Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice.

Authors:  Shuyi Chen; Jie Sun; Gang Zhao; Ai Guo; Yanlin Chen; Rongxia Fu; Yanqiu Deng
Journal:  Neurochem Res       Date:  2017-04-06       Impact factor: 3.996

Review 3.  Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis.

Authors:  Duraisamy Kempuraj; Govindhasamy P Selvakumar; Ramasamy Thangavel; Mohammad E Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Shankar S Iyer; Sachin M Bhagavan; Swathi Beladakere-Ramaswamy; Asgar Zaheer
Journal:  Front Neurosci       Date:  2017-12-12       Impact factor: 4.677

Review 4.  The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer's Disease.

Authors:  Olga N Kokiko-Cochran; Jonathan P Godbout
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 5.  The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.

Authors:  Holly M Brothers; Maya L Gosztyla; Stephen R Robinson
Journal:  Front Aging Neurosci       Date:  2018-04-25       Impact factor: 5.750

6.  Data on amyloid precursor protein accumulation, spontaneous physical activity, and motor learning after traumatic brain injury in the triple-transgenic mouse model of Alzheimer׳s disease.

Authors:  Yasushi Kishimoto; Hajime Shishido; Mayumi Sawanishi; Yasunori Toyota; Masaki Ueno; Takashi Kubota; Yutaka Kirino; Takashi Tamiya; Nobuyuki Kawai
Journal:  Data Brief       Date:  2016-08-26

Review 7.  Targeting Neuroinflammation to Treat Alzheimer's Disease.

Authors:  A Ardura-Fabregat; E W G M Boddeke; A Boza-Serrano; S Brioschi; S Castro-Gomez; K Ceyzériat; C Dansokho; T Dierkes; G Gelders; Michael T Heneka; L Hoeijmakers; A Hoffmann; L Iaccarino; S Jahnert; K Kuhbandner; G Landreth; N Lonnemann; P A Löschmann; R M McManus; A Paulus; K Reemst; J M Sanchez-Caro; A Tiberi; A Van der Perren; A Vautheny; C Venegas; A Webers; P Weydt; T S Wijasa; X Xiang; Y Yang
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

8.  The Delayed Neuroprotective Effect of Methylene Blue in Experimental Rat Brain Trauma.

Authors:  Elizaveta E Genrikhs; Elena V Stelmashook; Dmitriy N Voronkov; Svetlana V Novikova; Olga P Alexandrova; Mikhail V Gulyaev; Nickolay K Isaev
Journal:  Antioxidants (Basel)       Date:  2020-05-02

9.  A Systematic Review of Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats.

Authors:  Colleen N Bodnar; Kelly N Roberts; Emma K Higgins; Adam D Bachstetter
Journal:  J Neurotrauma       Date:  2019-03-06       Impact factor: 5.269

Review 10.  Axonal Degeneration in AD: The Contribution of Aβ and Tau.

Authors:  Natalia Salvadores; Cristian Gerónimo-Olvera; Felipe A Court
Journal:  Front Aging Neurosci       Date:  2020-10-15       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.